Pharsight

Sintetica Sa patents expiration

1. Iheezo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10792271 SINTETICA SA Topical formulations of chloroprocaine and methods of using same
Sep, 2038

(14 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Sep 27, 2025

Drugs and Companies using CHLOROPROCAINE HYDROCHLORIDE ingredient

Market Authorisation Date: 27 September, 2022

Treatment: Method of inducing ocular anesthesia

Dosage: GEL;OPHTHALMIC

More Information on Dosage

IHEEZO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic